1. Home
  2. NVCR vs ALM Comparison

NVCR vs ALM Comparison

Compare NVCR & ALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • ALM
  • Stock Information
  • Founded
  • NVCR 2000
  • ALM N/A
  • Country
  • NVCR Switzerland
  • ALM Canada
  • Employees
  • NVCR N/A
  • ALM N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • ALM Other Metals and Minerals
  • Sector
  • NVCR Health Care
  • ALM Basic Materials
  • Exchange
  • NVCR Nasdaq
  • ALM Nasdaq
  • Market Cap
  • NVCR 1.3B
  • ALM 1.5B
  • IPO Year
  • NVCR 2015
  • ALM N/A
  • Fundamental
  • Price
  • NVCR $12.04
  • ALM $5.60
  • Analyst Decision
  • NVCR Buy
  • ALM Strong Buy
  • Analyst Count
  • NVCR 7
  • ALM 2
  • Target Price
  • NVCR $28.64
  • ALM $12.00
  • AVG Volume (30 Days)
  • NVCR 1.7M
  • ALM 2.0M
  • Earning Date
  • NVCR 10-30-2025
  • ALM 11-03-2025
  • Dividend Yield
  • NVCR N/A
  • ALM N/A
  • EPS Growth
  • NVCR N/A
  • ALM N/A
  • EPS
  • NVCR N/A
  • ALM N/A
  • Revenue
  • NVCR $642,269,000.00
  • ALM $21,591,798.00
  • Revenue This Year
  • NVCR $9.54
  • ALM $108.36
  • Revenue Next Year
  • NVCR $5.70
  • ALM $169.35
  • P/E Ratio
  • NVCR N/A
  • ALM N/A
  • Revenue Growth
  • NVCR 11.17
  • ALM 7.50
  • 52 Week Low
  • NVCR $10.70
  • ALM $0.89
  • 52 Week High
  • NVCR $34.13
  • ALM $10.68
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 47.66
  • ALM 37.06
  • Support Level
  • NVCR $11.09
  • ALM $5.87
  • Resistance Level
  • NVCR $11.63
  • ALM $6.55
  • Average True Range (ATR)
  • NVCR 0.52
  • ALM 0.47
  • MACD
  • NVCR 0.05
  • ALM -0.16
  • Stochastic Oscillator
  • NVCR 86.51
  • ALM 7.59

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About ALM Almonty Industries Inc. Common Shares

Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.

Share on Social Networks: